Search results

Beamtime Guide on the X-ray Fluorescence Microscopy beamline at the Australian Synchrotron.

The final report on the safety of Building 23 by the independent expert review team has been completed.

Collaboration across the Tasman has enabled Australian and New Zealand researchers and scientists to shed light on a protein involved in diseases such as Parkinson’s disease, gastric cancer and melanoma.

Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.

An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.

ANSTO is expanding its global connections, with the nandin Innovation Centre joining an international network created to increase cross industry collaboration and co-creation.

Principal Technical Consultant Michael Druce shares some personal insights on the design and construction of ANSTO's nuclear medicine facility.

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

Project members of Magnetism.

Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.

The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.

International interest is building in Australia’s new multi-million-dollar radioactive waste processing facility at the Sydney campus of the Australian Nuclear Science and Technology Organisation (ANSTO).

The Australian Synchrotron provides funding support for successful beamtime applicants in the form of travel funding and/or onsite accommodation. Travel funds granted are to be used solely to cover the majority of the cost to travel to the AS facility. The User Office will book accommodation for interstate user groups at the onsite AS Guesthouse.

New researcher joins human health team to focus on role of acquired immunity in preventing disease

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.